Actively Recruiting
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Led by Novo Nordisk A/S · Updated on 2025-12-05
470
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Participant will get oral semaglutde as prescribed by the study doctor. The study will last for about 26 ± 4 weeks (5 to 7 months). Participant will be asked to complete a questionnaire about how they take oral semaglutide tablets during normal scheduled visit with doctor. Participant will also be asked questions about health and their diabetes treatment and lab tests as part of normal doctor's appointment.
CONDITIONS
Official Title
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed consent obtained before any study-related activities.
- Decision to start oral semaglutide made by patient or legal authorized representative and treating physician based on local label before study inclusion.
- Adults aged 18 years or older at the time of consent.
- Diagnosed with type 2 diabetes mellitus.
- Currently on metformin with or without other oral antidiabetic drugs (DPP4i or SGLT2i) and/or insulin therapy.
- Available HbA1c value greater than 7.0% within 90 days before or at the treatment initiation visit.
You will not qualify if you...
- Previous participation in this study.
- Treatment with any investigational drug within 30 days before enrollment.
- Mental incapacity, unwillingness, or language barriers preventing understanding or cooperation.
- Treatment with GLP1-RA within 90 days before treatment initiation.
- Diagnosis of type 1 diabetes mellitus.
- Female who is pregnant, breastfeeding, undergoing fertility treatment, or planning pregnancy during the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Siklósi Kórház, Diabetológia
Siklós, Hungary, 7801
Actively Recruiting
Research Team
N
Novo Nordisk
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here